Glenzocimab: A GPVI (Glycoprotein VI)-Targeted Potential Antiplatelet Agent for the Treatment of Acute Ischemic Stroke. Wichaiyo S, Parichatikanond W, Rattanavipanon W. Stroke 2022 Sep 21:101161STROKEAHA122039790. doi: 10.1161/STROKEAHA.122.039790.

Read + Share

Amedeo Smart

Independent Medical Education

Wichaiyo S, Parichatikanond W, Rattanavipanon W. Glenzocimab: A GPVI (Glycoprotein VI)-Targeted Potential Antiplatelet Agent for the Treatment of Acute Ischemic Stroke. Stroke 2022 Sep 21:101161STROKEAHA122039790. doi: 10.1161/STROKEAHA.122.039790.
PMID: 36128904